SCHEMBL6632697

SCHEMBL6632697

CCS(=O)(=O)c1ccc(NC(=O)c2n[nH]c3c2CCc2ccccc2-3)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.48
MAPT P10636 5/20 0.48
KDM4E B2RXH2 1/20 0.48
NPC1 O15118 7/20 0.47
SMN1; SMN2 Q16637 5/20 0.46
CDK2 P24941 1/20 0.42
PRKDC P78527 1/20 0.42
ATR Q13535 1/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CSNK2A1 P68400 1/20 0.40
RORC P51449 4/20 0.39
TP53 P04637 3/20 0.39
THRB P10828 1/20 0.39
AGTR1 P30556 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
PAX8 Q06710 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10187028 0.84 SMN1; SMN2 (0.52) RAB9AMAPTNPC1SMN1; SMN2MEN1
SCHEMBL6195935 0.84 RAB9A (0.49) RAB9AMAPTKDM4ENPC1SMN1; SMN2
SCHEMBL2187619 0.83 RAB9A (0.48) RAB9AMAPTKDM4ENPC1SMN1; SMN2
SCHEMBL6681499 0.82 RAB9A (0.47) RAB9AMAPTKDM4ENPC1SMN1; SMN2
SCHEMBL10187027 0.80 SMN1; SMN2 (0.51) RAB9AMAPTKDM4ENPC1SMN1; SMN2
SCHEMBL21909759 0.78 RAB9A (0.52) RAB9AMAPTKDM4ENPC1SMN1; SMN2
SCHEMBL6198600 0.77 NPC1 (0.64) RAB9AMAPTNPC1SMN1; SMN2MEN1
SCHEMBL21376322 0.73 RAB9A (0.46) RAB9AMAPTKDM4ENPC1SMN1; SMN2
SCHEMBL3206132 0.72 GSR (0.53) RAB9AKDM4ENPC1CDK2KMT2A
SCHEMBL6644918 0.71 CDK2 (0.54) MAPTSMN1; SMN2CDK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444207-A2 SUBSTITUTED PYRAZOLYL-COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2004-08-11 EP disclosed
WO-2003024935-A2 SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-03-27 WO disclosed